Vibostolimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Vibostolimab Usage And Synthesis

Uses

Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research[1].

References

[1] Niu J, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆. Ann Oncol. 2022 Feb;33(2):169-180. DOI:10.1016/j.annonc.2021.11.002

Vibostolimab(2231305-30-7)Related Product Information

• Atezolizumab
• Sutimlimab
• Naxitamab
• Semorinemab
• Raxibacumab
• Camrelizumab
• Durvalumab
• Abituzumab
• Belantamab
• catumaxomab